… In our study, we found a significantly prolonged survival in patients who responded to IFN.
A … patients treated with interferon. Most studies compared the survival of IFN treated patients …

… IFN-α for treatment of patients with disseminated mycobacterial disease in an effort to
complement their IFN… We describe four patients with mutations in the IFN-γ receptor whose …

… interferon (IFN-I) pathway, and particularly interferon alpha (IFNα) in SLE pathogenesis. As a
result, a multitude of potential treatments … Some of the treatment strategies have focused on …

… These findings raised the question of how long do we need to treat our patients with
interferon-alpha once they achieve a CCyR, and can RT-PCR help guide the decision to …

… Cuban overall CFR was 3.70% whereas in patients treated with IFN alpha-2b it was 0.92%.
Both … evaluation revealed that there were more patients not treated with IFN-α2b who had an …

… Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic
phase CML patients treated with imatinib after failure of interferon alpha. Leukemia 2002; 16…

… Interferon alpha (IFN) inhibits the growth of megakaryocytic progenitors in normal hematopoiesis
and in patients with essential thrombocythemia (ET) leading to a reduction of peripheral …

… CONCLUSION: Interferon treatment on Hepatitis B and combined with other type Hepatitis
virus … Interferon alpha treatment for chronic Hepatitis B had higher efficacy than the complex …

… C who were treated with standard interferon alpha plus ribavirin … during combination treatment
with pegylated interferons and … the treatment of chronic HCV infection with pegylated IFN-α …

… Interferon alpha-2a (IFN-α2a) seems to be an alternative to anti-… Its efficacy and tolerance
have been analysed in patients … that IFN-α2a had no or only partial efficacy in these patients. …